So my friend, Justin Morgenstern recently put up a post on Idarucizumab, aka Praxbind. He seemed pretty fired up on the issue, so I got him on the line to talk about it. What follows is a conversation on evidence and what to do when there is not a good amount of it.
The EM Cases Podcast that partially sparked the debate
Justin Wrote an Additional Post after our Discussion
On Parachutes and Such
On to the Wee...
Länk till avsnitt